Questions about the 10 x '20 Initiative

被引：5

作者：

Outterson, Kevin ^{[1
]}

Powers, John H., III ^{[4
]}

Gould, Ian M. ^{[5
]}

Kesselheim, Aaron S. ^{[2
,3
]}

机构：

[1] Boston Univ, Sch Law, Boston, MA 02215 USA

[2] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] NIH, Sci Applicat Int Corp, Bethesda, MD 20892 USA

[5] Aberdeen Royal Infirm, Dept Med Microbiol, Aberdeen, Scotland

来源：

CLINICAL INFECTIOUS DISEASES | 2010年 / 51卷 / 06期

关键词：

D O I：

10.1086/655955

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：751 / 752

页数：2

共 8 条

[1] Meeting the challenge of antibiotic resistance [J].

Cars, Otto ;

Hogberg, Liselotte Diaz ;

Murray, Mary ;

Nordberg, Olle ;

Sivaraman, Satya ;

Lundborg, Cecilia Stalsby ;

So, Anthony D. ;

Tomson, Goran .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7672) :a1438

[2] The price of innovation: new estimates of drug development costs [J].

DiMasi, JA ;

Hansen, RW ;

Grabowski, HG .

JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) :151-185

[3] The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020 [J].

Gilbert, David N. ;

Guidos, Robert J. ;

Boucher, Helen W. ;

Talbot, George H. ;

Spellberg, Brad ;

Edwards, John E., Jr. ;

Scheld, W. Michael ;

Bradley, John S. ;

Bartlett, John G. .

CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) :1081-1083

[4]

KESSELHEIM AS, 2010, YALE J HLTH IN PRESS

[5]

Laxminarayan R., 2007, EXTENDING CURE POLIC

[6] Will longer antimicrobial patents improve global public health? [J].

Outterson, Kevin ;

Samora, Julie Balch ;

Keller-Cuda, Karen .

LANCET INFECTIOUS DISEASES, 2007, 7 (08) :559-566

[7] Increasing the efficiency of clinical trials of antimicrobials: The scientific basis of substantial evidence of effectiveness of drugs [J].

Powers, John H. .

CLINICAL INFECTIOUS DISEASES, 2007, 45 :S153-S162

[8]

*PUBL CIT, RX R D MYTHS CAS DRU

← 1 →